1. Home
  2. BEAM vs CNMD Comparison

BEAM vs CNMD Comparison

Compare BEAM & CNMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BEAM
  • CNMD
  • Stock Information
  • Founded
  • BEAM 2017
  • CNMD 1970
  • Country
  • BEAM United States
  • CNMD United States
  • Employees
  • BEAM N/A
  • CNMD N/A
  • Industry
  • BEAM Biotechnology: Biological Products (No Diagnostic Substances)
  • CNMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • BEAM Health Care
  • CNMD Health Care
  • Exchange
  • BEAM Nasdaq
  • CNMD Nasdaq
  • Market Cap
  • BEAM 1.9B
  • CNMD 2.1B
  • IPO Year
  • BEAM 2020
  • CNMD 1987
  • Fundamental
  • Price
  • BEAM $24.41
  • CNMD $70.87
  • Analyst Decision
  • BEAM Buy
  • CNMD Buy
  • Analyst Count
  • BEAM 10
  • CNMD 6
  • Target Price
  • BEAM $47.67
  • CNMD $82.83
  • AVG Volume (30 Days)
  • BEAM 1.2M
  • CNMD 400.0K
  • Earning Date
  • BEAM 02-25-2025
  • CNMD 02-05-2025
  • Dividend Yield
  • BEAM N/A
  • CNMD 1.13%
  • EPS Growth
  • BEAM N/A
  • CNMD 127.53
  • EPS
  • BEAM N/A
  • CNMD 4.22
  • Revenue
  • BEAM $349,643,000.00
  • CNMD $1,288,116,000.00
  • Revenue This Year
  • BEAM N/A
  • CNMD $6.69
  • Revenue Next Year
  • BEAM $14.08
  • CNMD $7.53
  • P/E Ratio
  • BEAM N/A
  • CNMD $16.74
  • Revenue Growth
  • BEAM 328.73
  • CNMD 10.23
  • 52 Week Low
  • BEAM $20.84
  • CNMD $61.05
  • 52 Week High
  • BEAM $49.50
  • CNMD $101.71
  • Technical
  • Relative Strength Index (RSI)
  • BEAM 42.12
  • CNMD 54.91
  • Support Level
  • BEAM $22.50
  • CNMD $66.38
  • Resistance Level
  • BEAM $28.39
  • CNMD $71.23
  • Average True Range (ATR)
  • BEAM 1.56
  • CNMD 2.71
  • MACD
  • BEAM -0.33
  • CNMD 0.15
  • Stochastic Oscillator
  • BEAM 27.67
  • CNMD 88.89

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing. The company's pipeline programs consist of BEAM-101, ESCAPE, BEAM-302, BEAM-301, and BEAM-201.

About CNMD CONMED Corporation

Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The firm currently reports through two reporting units, orthopedic surgery, and general surgery. From a geographic perspective, the firm is U.S.-centric, with maximum domestic sales accounting for revenue, EMEA accounting for second place, APAC at third, and the non-U.S. Americas region driving the remaining revenue.

Share on Social Networks: